A 2009 study, cited as a “key scientific discovery” by Genentech as it sought a higher valuation, has now been retracted by former University head Marc Tessier-Lavigne. It is his fourth retraction in as many months.
The biotechnology firm revealed new allegations of research misconduct in Marc Tessier-Lavigne’s lab and disclosed more potential image alterations while saying that its potentially “incomplete” findings did not prove fraud in a contested 2009 study.
Stanford University president Marc Tessier-Lavigne was formerly executive vice president for research and chief scientific officer at biotech giant Genentech, according to his page on Wikipedia. "In 2022, Stanford University opened an investigation into allegations of Tessier-Lavigne s involvement.
His paper was called “the miracle result.” But it never turned into an Alzheimer’s treatment. Now, four former Genentech senior scientists and executives allege that an internal review in 2011 discovered the paper had been based on fabricated research and that Marc Tessier-Lavigne kept the results of the review from becoming public. He denies the allegations.